BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25081532)

  • 1. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals.
    Orian-Rousseau V; Sleeman J
    Adv Cancer Res; 2014; 123():231-54. PubMed ID: 25081532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
    Misra S; Hascall VC; Berger FG; Markwald RR; Ghatak S
    Connect Tissue Res; 2008; 49(3):219-24. PubMed ID: 18661347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors.
    Kouvidi K; Nikitovic D; Berdiaki A; Tzanakakis GN
    Adv Cancer Res; 2014; 123():319-49. PubMed ID: 25081535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly.
    Knudson CB
    Birth Defects Res C Embryo Today; 2003 May; 69(2):174-96. PubMed ID: 12955860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan and CD44: modulators of chondrocyte metabolism.
    Knudson CB; Knudson W
    Clin Orthop Relat Res; 2004 Oct; (427 Suppl):S152-62. PubMed ID: 15480059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
    Bajorath J
    Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction via CD44: role of plasma membrane microdomains.
    Ilangumaran S; Borisch B; Hoessli DC
    Leuk Lymphoma; 1999 Nov; 35(5-6):455-69. PubMed ID: 10609783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 in hematological neoplasias.
    Hertweck MK; Erdfelder F; Kreuzer KA
    Ann Hematol; 2011 May; 90(5):493-508. PubMed ID: 21258793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis.
    Heldin P; Karousou E; Bernert B; Porsch H; Nishitsuka K; Skandalis SS
    Connect Tissue Res; 2008; 49(3):215-8. PubMed ID: 18661346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The liberation of CD44.
    Cichy J; Puré E
    J Cell Biol; 2003 Jun; 161(5):839-43. PubMed ID: 12796473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer.
    Skandalis SS; Gialeli C; Theocharis AD; Karamanos NK
    Adv Cancer Res; 2014; 123():277-317. PubMed ID: 25081534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
    Wang SJ; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A; Takahashi K; Cutler M; Tanabe KK
    Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of CD44 targeting therapies.
    Orian-Rousseau V; Ponta H
    Arch Toxicol; 2015 Jan; 89(1):3-14. PubMed ID: 25472903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan receptors involved in cytokine induction in monocytes.
    Yamawaki H; Hirohata S; Miyoshi T; Takahashi K; Ogawa H; Shinohata R; Demircan K; Kusachi S; Yamamoto K; Ninomiya Y
    Glycobiology; 2009 Jan; 19(1):83-92. PubMed ID: 18854367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronidase can modulate expression of CD44.
    Stern R; Shuster S; Wiley TS; Formby B
    Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group A Streptococcus tissue invasion by CD44-mediated cell signalling.
    Cywes C; Wessels MR
    Nature; 2001 Dec; 414(6864):648-52. PubMed ID: 11740562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
    Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
    J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.